Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aimed to assess the effectiveness of the Subconjunctival bupivacaine on postoperative pain in Strabismus surgery under general anaesthesia.
40 patients will schedule for elective Strabismus surgery under general anaesthesia and randomly allocated into two groups to receive Subconjunctival 0.5%Bupivacaine group(B) or Subconjunctival placebo 0.9% normal saline group at the end of the surgery and assess the postoperative pain at 0th,30th, 60th,2nd h, 4h,6h,12h,24h.and post operative nausea and vomiting.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 20 patients receive Subconjunctival bupivacaine of the end of the surgery | Active Comparator | 20 patients receive Subconjunctival bupivacaine in the end of operation and monitoring postoperative pain score |
|
| 20 patients receive Subconjunctival placebo in the end of operation | Placebo Comparator | 20 patients receive Subconjunctival placebo in the end of operation and monitoring postoperative pain score |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Iocal anaesthetic bupivacaine | Drug | Local anaesthetic Subconjunctival bupivacaine |
|
| Measure | Description | Time Frame |
|---|---|---|
| Visual analog scale (VAS) pain score | Range, 0_10;0,no pain ;10,worst pain | 5 minutes after extubation |
| Measure | Description | Time Frame |
|---|---|---|
| Nausea and vomiting | Operation related side effect | 24 hours postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| Patient satisfaction | Will be evaluated according to satisfaction score (poor=0, fair=1, good=2, excellent=3) | 24 hours postoperatively |
| Visual analog scale (VAS) pain score | Range, 0_10;0,no pain ;10,worst pain |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Abeer Sh Goda | Contact | 01005151706 | Asg06@fayoum.edu.eg | |
| Amr H Mahmoud, Msc | Contact | 01004349592 | 002 | Ah1240@fayoum.edu.eg |
| Name | Affiliation | Role |
|---|---|---|
| Mohammad A Hamed, MD | Fayoum University Hospital | Study Director |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D044382 | Population Groups |
| ID | Term |
|---|---|
| D003710 | Demography |
| D011154 | Population Characteristics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo | Drug | 0.9 saline |
|
|
| 30 minutes after extubation |
| Visual analog scale (VAS) pain score | Range, 0_10;0,no pain ;10,worst pain | 60 minutes after extubation |
| Visual analog scale (VAS) pain score | Range, 0_10;0,no pain ;10,worst pain | 2 hours after extubation |
| Visual analog scale (VAS) pain score | Range, 0_10;0,no pain ;10,worst pain | 4 hours after extubation |
| Visual analog scale (VAS) pain score | Range, 0_10;0,no pain ;10,worst pain | 6 hours after extubation |
| Visual analog scale (VAS) pain score | Range, 0_10;0,no pain ;10,worst pain | 12 hours after extubation |
| Visual analog scale (VAS) pain score | Range, 0_10;0,no pain ;10,worst pain | 24 hours after extubation |